MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma

European Journal of Endocrinology

Volumn 162, Issue 6, 2010, Pages 1027-1033

  Hsu, Chih Yi ^a,b   Guo, Wan Yuo ^a,b   Chien, Chen Ping ^a   Ho, Donald Ming Tak ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GROWTH RATE; HUMAN; HYPOPHYSIS ADENOMA; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MIB 1 LABELING INDEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROGNOSIS; TUMOR BURDEN;

EID: 77952724702     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1100     Document Type: Article

References (28)

1. Hoshi M, Hayashi T, Kagami H, Murase I & Nakatsukasa M. Late bilateral temporal lobe necrosis after conventional radiotherapy. Neurologia Medico-Chirurgica 2003 43 213-216. (Pubitemid 36553082)
2. Piatt JH Jr, Blue JM, Schold SC Jr & Burger PC. Glioblastoma multiforme after radiotherapy for acromegaly. Neurosurgery 1983 13 85-89.
3. Bhansali A, Banerjee AK, Chanda A, Singh P, Sharma SC, Mathuriya SN & Dash RJ. Radiation-induced brain disorders in patients with pituitary tumours. Australasian Radiology 2004 48 339-346. (Pubitemid 39421078)
4. Gerdes J, Becker MH, Key G & Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. Journal of Pathology 1992 168 85-86.
5. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J & Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Journal of Pathology 1992 168 357-363. (Pubitemid 23013251)
6. Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T & Hirohata T. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas. Acta Neurochirurgica 1995 136 37-43.
7. Ekramullah SM, Saitoh Y, Arita N, Ohnishi T & Hayakawa T. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochirurgica 1996 138 1449-1455. (Pubitemid 27010696)
8. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D & Laws ER Jr. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996 38 99-106. discussion 106-107.
9. Abe T, Sanno N, Osamura YR & Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochirurgica 1997 139 613-618. (Pubitemid 27298211)
10. Mizoue T, Kawamoto H, Arita K, Kurisu K, Tominaga A & Uozumi T. MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochirurgica 1997 139 426-431. discussion 431-432.
11. Yonezawa K, Tamaki N & Kokunai T. Clinical features and growth fractions of pituitary adenomas. Surgical Neurology 1997 48 494-500. (Pubitemid 27463625)
12. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F & Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. Journal of Clinical Pathology 1999 52 107-111. (Pubitemid 29062344)
13. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, Mortini P & Giovanelli M. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery 2000 47 1313-1318. discussion 1318-1319.
14. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Ruggeri A & Peciarolo A. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody. Tumori 2000 86 229-232. (Pubitemid 30470743)
15. Lath R, Chacko G & Chandy MJ. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody. Neurology India 2001 49 144-147. (Pubitemid 32691251)
16. Mastronardi L, Guiducci A & Puzzilli F. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas. BMC Cancer 2001 1 12. (Pubitemid 38846507)
17. Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, Santoro A, Faticanti Scucchi L, Gulino A & Cantore G. A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocrine-Related Cancer 2002 9 103-113. (Pubitemid 34832163)
18. Hentschel SJ, McCutcheon E, Moore W & Durity FA. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Canadian Journal of Neurological Sciences 2003 30 215-219. (Pubitemid 37064515)
19. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Monting J & Reincke M. Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. Journal of Neurosurgery 2003 99 674-679. (Pubitemid 37159044)
20. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y & Kobayashi S. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. Journal of Neurosurgery 2003 98 359-365. (Pubitemid 36151032)
21. Wolfsberger S, Kitz K, Wunderer J, Czech T, Boecher-Schwarz HG, Hainfellner JA & Knosp E. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas. Acta Neurochirurgica 2004 146 1323-1327. discussion 1327-1328.
22. Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Bocher-Schwarz HG, Hainfellner J & Knosp E. Expression of cell proliferation markers in pituitary adenomas - correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Acta Neurochirurgica 2004 146 831-839.
23. Dubois S, Guyetant S, Menei P, Rodien P, Illouz F, Vielle B & Rohmer V. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. European Journal of Endocrinology 2007 157 141-147. (Pubitemid 47233117)
24. Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F, Angelini F, Lauriola L, Vellone V, Doglietto F, Ambrosio MR, Maira G, Giustina A, degli Uberti EC, Pontecorvi A & De Marinis L. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2008 93 2746-2750.
25. Gejman R, Swearingen B & Hedley-Whyte ET. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Human Pathology 2008 39 758-766. (Pubitemid 351601606)
26. Schreiber S, Saeger W & Lüdecke DK. Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1999 1 213-220.
27. Saeger W, Lüdecke B & Lüdecke DK. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas. Experimental and Clinical Endocrinology and Diabetes 2008 116 80-85. (Pubitemid 351363376)
28. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T & Kirino T. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 1999 85 2249-2254. (Pubitemid 29215566)